Showing 541 - 560 results of 226,387 for search '(( 10 ((mg decrease) OR (a decrease)) ) OR ( 50 ((mean decrease) OR (we decrease)) ))', query time: 1.52s Refine Results
  1. 541
  2. 542
  3. 543
  4. 544
  5. 545
  6. 546

    Receptor specific silencing decreases NGF induced apoptosis. by Alessandra Micera (294762)

    Published 2013
    “…A 37.5%-decrease (*) and a 50%-decrease (**) of apoptotic signal were detected respectively in p75<sup>NTR</sup>-siRNA and p75<sup>NTR</sup>/trkA<sup>NGFR</sup>-siRNA (p<.05).…”
  7. 547

    Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…One hundred percent cell viability corresponds to the number of living cells incubated with transfecting agent only. Results are the mean ± SD of two independent experiments containing 8 replicates for each condition. * = <i>p</i><0.05, ** = <i>p</i><0.01, *** = <i>p</i><0.001, significant decrease compared to untreated cells (TA) or to siRNA Control (Kruskal & Wallis followed by Tukey and Dunnet test).…”
  8. 548
  9. 549
  10. 550
  11. 551

    Astrocytic AQP4 is decreased in aged cortical astrocytes. by Ileana Soto (531878)

    Published 2015
    “…<p>(A) AQP4 immunoreactivity (blue) and protein levels (B) are significantly decreased in the aged cortex. …”
  12. 552
  13. 553
  14. 554
  15. 555
  16. 556
  17. 557
  18. 558

    Zolpidem decreased frequencies of calcium transients in CA1. by Tamara Berdyyeva (654876)

    Published 2014
    “…<p><b>A</b>: Calcium transients (indicated by tick marks) detected in individual cells (vertical axis) are plotted across time following vehicle (water, left) and Zolpidem (10 mg/kg, right) administration in a representative animal. …”
  19. 559
  20. 560

    Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer by Giorgia Urbinati (554921)

    Published 2015
    “…<div><p><i>TMPRSS2-ERG</i> junction oncogene is present in more than 50% of patients with prostate cancer and its expression is frequently associated with poor prognosis. …”